MITOCHONDRIAL dysfunction is gaining prominence in healthcare, as acknowledged by the Australian Govt, with health rebates for mitochondrial dysfunction testing.
A Dutch study, published in this month's Nature Communications, delved into the energy production efficiency of mitochondria in COVID-affected patients compared to healthy individuals, revealing a shortfall during a cycling test.
This deficiency triggered post-exertional malaise, emphasising the impact of physical, cognitive, or emotional stress.
Analyses of blood and muscle tissue unveiled abnormalities in the muscle mitochondria of patients, underscoring their reduced effectiveness in energy production.
With more than 90 studies supporting ubiquinol's role in mitochondrial health, it may emerge as a potential frontline therapy for conditions including heart health, fertility, energy and fatigue.
See more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 24
